182 related articles for article (PubMed ID: 14587161)
1. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case.
Morais J; Dias B; Pontes N
Rev Port Cardiol; 2003; 22(7-8):941-8. PubMed ID: 14587161
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
5. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
6. A promising new inotrope: levosimendan.
Fotbolcu H; Duman D
Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan: implications for clinicians.
McBride BF; White CM
J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
Cleland JG; Nikitin N; McGowan J
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
[TBL] [Abstract][Full Text] [Related]
9. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure].
Porcu M; Orrù P
Ital Heart J Suppl; 2001 Feb; 2(2):205-6. PubMed ID: 11255888
[No Abstract] [Full Text] [Related]
10. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
Nieminen MS; Sandell EP
Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
Int J Cardiol; 2010 Feb; 138(3):281-9. PubMed ID: 18817994
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trials with levosimendan.
Mebazaa A; Barraud D; Welschbillig S
Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826
[TBL] [Abstract][Full Text] [Related]
14. The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
de Lissovoy G; Fraeman K; Salon J; Chay Woodward T; Sterz R
J Med Econ; 2008; 11(3):415-29. PubMed ID: 19450096
[TBL] [Abstract][Full Text] [Related]
15. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan: current status and future prospects.
Archan S; Toller W
Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
[TBL] [Abstract][Full Text] [Related]
17. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
Mebazaa A; Erhardt L
Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based use of levosimendan in different clinical settings.
De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
